Clin Mol Hepatol.
2024 Oct;30(4):705-708. 10.3350/cmh.2024.0372.
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
- Affiliations
-
- 1Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
- KMID: 2560076
- DOI: http://doi.org/10.3350/cmh.2024.0372
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
- Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
- Hepatocellular Carcinoma Arising from Non-Cirrhotic Non-Alcoholic Steatohepatitis
